Related references
Note: Only part of the references are listed.Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma
Josefin Hidman et al.
ACTA HAEMATOLOGICA (2022)
Natural Killer Cells in the Malignant Niche of Multiple Myeloma
Ondrej Venglar et al.
FRONTIERS IN IMMUNOLOGY (2022)
Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities
Leona Yamamoto et al.
FRONTIERS IN ONCOLOGY (2021)
A novel form of anti-angiogenic molecular antibody drug induces apoptosis in myeloma cells after cultivation upon endothelial feeder cells
Yavar Yousefi et al.
LEUKEMIA RESEARCH (2021)
Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model
Hiroki Satooka et al.
SCIENTIFIC REPORTS (2020)
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients
Roberto Ria et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The role of microenvironment in tumor angiogenesis
Xianjie Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Multiomic analysis of cytokines in immuno-oncology
Vladimir Jurisic
EXPERT REVIEW OF PROTEOMICS (2020)
VEGF in Signaling and Disease: Beyond Discovery and Development
Rajendra S. Apte et al.
CELL (2019)
Vascular endothelial growth factor (VEGF) impairs the motility and immune function of human mature dendritic cells through the VEGF receptor 2-RhoA-cofilin1 pathway
Jinhua Long et al.
CANCER SCIENCE (2019)
Extracellular Vesicles Enhance Multiple Myeloma Metastatic Dissemination
Michela Colombo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Targeting veGF/veGFR to Modulate Antitumor immunity
Ju Yang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model
Amanda Contreras et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis
Ewelina Krzywinska et al.
NATURE COMMUNICATIONS (2017)
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
Asis Palazon et al.
CANCER CELL (2017)
Decreased CD161 activating and increased CD158a inhibitory receptor expression on NK cells underlies impaired NK cell cytotoxicity in patients with multiple myeloma
Gordana Konjevic et al.
JOURNAL OF CLINICAL PATHOLOGY (2016)
VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma
Xinqi Wu et al.
CANCER IMMUNOLOGY RESEARCH (2016)
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
Thibault Voron et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
A role for CCL28-CCR3 in T-cell homing to the human upper airway mucosa
E. Danilova et al.
MUCOSAL IMMUNOLOGY (2015)
Restoration of natural killer cell cytotoxicity by VEGFR-3 inhibition in myelogenous leukemia
Ji Yoon Lee et al.
CANCER LETTERS (2014)
Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Decisions About Dendritic Cells: Past, Present, and Future
Ralph M. Steinman
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Cutting Edge: Vascular Endothelial Growth Factor-Mediated Signaling in Human CD45RO+ CD4+ T Cells Promotes Akt and ERK Activation and Costimulates IFN-γ Production
Aninda Basu et al.
JOURNAL OF IMMUNOLOGY (2010)
Biological impact of vascular endothelial growth factor on vessel density and survival in multiple myeloma and plasmacytoma
Wael M. Swelam et al.
PATHOLOGY RESEARCH AND PRACTICE (2010)
Dendritic cells in vivo: A key target for a new vaccine science
Ralph M. Steinman
IMMUNITY (2008)
Clinical stage-depending decrease of NK cell activity in multiple myeloma patients
Vladimir Jurisic et al.
MEDICAL ONCOLOGY (2007)
Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome
M. J. Cuadrado et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
DJ Hicklin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Angiogenesis-inflammation cross-talk: Vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization
F Mor et al.
JOURNAL OF IMMUNOLOGY (2004)
Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: Role of vascular endothelial growth factor
JL Owen et al.
JOURNAL OF IMMUNOLOGY (2003)
Expression of VEGF and its receptors by myeloma cells
S Kumar et al.
LEUKEMIA (2003)
VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression
JE Ohm et al.
BLOOD (2003)
Purified protein derivative of tuberculin upregulates the expression of vascular endothelial growth factor in T lymphocytes in vitro
W Matsuyama et al.
IMMUNOLOGY (2002)
Vascular endothelial growth factor (VEGF) expression in plasmacytoma
S Paydas et al.
LEUKEMIA & LYMPHOMA (2002)
Inhibition of interieukin-10 (IL-10) production from MOPC 315 tumor cells by IL-10 antisense oligodeoxynucleotides enhances cell-mediated immune responses
BG Kim et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2000)
Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma
B Dankbar et al.
BLOOD (2000)
Share Paper
